1. Home
  2. CVAC vs CLMT Comparison

CVAC vs CLMT Comparison

Compare CVAC & CLMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • CLMT
  • Stock Information
  • Founded
  • CVAC 2000
  • CLMT 1916
  • Country
  • CVAC Germany
  • CLMT United States
  • Employees
  • CVAC N/A
  • CLMT 1630
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • CLMT Oil & Gas Production
  • Sector
  • CVAC Health Care
  • CLMT Energy
  • Exchange
  • CVAC Nasdaq
  • CLMT Nasdaq
  • Market Cap
  • CVAC 1.2B
  • CLMT 1.2B
  • IPO Year
  • CVAC 2020
  • CLMT 2006
  • Fundamental
  • Price
  • CVAC $5.48
  • CLMT $13.80
  • Analyst Decision
  • CVAC Hold
  • CLMT Strong Buy
  • Analyst Count
  • CVAC 3
  • CLMT 6
  • Target Price
  • CVAC $6.83
  • CLMT $20.38
  • AVG Volume (30 Days)
  • CVAC 789.9K
  • CLMT 771.0K
  • Earning Date
  • CVAC 08-18-2025
  • CLMT 08-08-2025
  • Dividend Yield
  • CVAC N/A
  • CLMT N/A
  • EPS Growth
  • CVAC N/A
  • CLMT N/A
  • EPS
  • CVAC 0.87
  • CLMT N/A
  • Revenue
  • CVAC $566,039,775.00
  • CLMT $4,070,400,000.00
  • Revenue This Year
  • CVAC N/A
  • CLMT N/A
  • Revenue Next Year
  • CVAC $24.04
  • CLMT N/A
  • P/E Ratio
  • CVAC $6.35
  • CLMT N/A
  • Revenue Growth
  • CVAC 787.60
  • CLMT N/A
  • 52 Week Low
  • CVAC $2.37
  • CLMT $7.68
  • 52 Week High
  • CVAC $5.72
  • CLMT $25.29
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 60.60
  • CLMT 36.67
  • Support Level
  • CVAC $5.41
  • CLMT $13.01
  • Resistance Level
  • CVAC $5.54
  • CLMT $14.49
  • Average True Range (ATR)
  • CVAC 0.05
  • CLMT 0.81
  • MACD
  • CVAC -0.01
  • CLMT -0.26
  • Stochastic Oscillator
  • CVAC 73.68
  • CLMT 25.56

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About CLMT Calumet Specialty Products Partners L.P. Common Units

Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.

Share on Social Networks: